Becker's Healthcare March 22, 2023
Cognito Therapeutics, a neurotechnology company creating therapies for central nervous system diseases, raised $73 million in a series B financing round.
The funding will be used to advance a study of Cognito’s flagship neuromodulation device. The latest funding round brings the company’s total raised to $93 million, according to...